N/A N=120 Clearblue Home Pregnancy Test Consumer Study
Pregnancy
Primary: Consumer Agreement — 100 percentage of agreement
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=30 Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing
Pregnancy Testing
Primary: Number of Participants With Positive POC Serum Pregnancy Test — 30 Participants
N/A N=51 The Role of a Semi-Quantitative Urine Pregnancy Test and Pregnancy Questionnaire After Uterine Evacuation for Undesired Pregnancy of Uncertain Location
Follow-up After Uterine Evacuation
Primary: Number of Women in Each Group Who Require a Return Visit to the Clinic for a Serum hCG Measurement, Ultrasound or Clinical Examination at One Week to Confirm Complete…
N/A N=106 Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP
HIV-1-infection
Primary: Recent PrEP Adherence — 33; 18 Participants — p=<0.001
N/A N=20 Patient Centered Postpartum Contraception App
Contraceptive Usage
Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale
N/A N=83 FreeStyle Libre in Pregnancy Study
Diabetes Mellitus
Primary: Point Accuracy Determined as % Within Consensus Error Grid Zone A — 88.1 percentage of results
N/A N=150 Psychological Impact of Pregnancy of Unknown Location
Pregnancy of Unknown Location · Ectopic Pregnancy · Anxiety
Primary: Psychological Morbidity — 10; 10; 5; 5 score on a scale
Phase 4 N=50 Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
Post Partum
Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants
N/A N=38 Pilot Testing a New Pregnancy Decision Making Tool for Women With Physical Disabilities
Disability Physical
Primary: Final Decisional Conflict Scale Score - Values Clarity Sub-scale — 13.1 units on a scale
N/A N=395 Clearblue Advanced Fertility Monitor Consumer One Cycle at Home Study
Pregnancy
Primary: The Ability of the Volunteer to Use the New Clearblue Advanced Fertility Monitoring a Home Setting — 89.7 percentage of participants
N/A N=222 Human Repeat Insult Patch Test to Evaluate Personal Lubricants
Erythema · Edema
Primary: Number of Patients That Showed Sensitization Reaction to the Test Material at Challenge — 0 Participants
N/A N=146 Reducing Teen Pregnancy in the Emergency Department
Reproductive Behavior · Sexual Behavior · Adolescent Behavior
Primary: Potential Efficacy: Effective Contraception Initiation Rates [Time Frame: Enrollment, 12 Weeks Post-enrollment (2 Weeks Post Close of Intervention)] — 14; 14 Participants
N/A N=151 Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects
Pregnancy
Primary: Fetal Heart Rate — 140.3; 140.4 bpm
N/A N=990 Testing the Impact of Two Posters on Contraceptive Knowledge, Contraceptive Preferences, and Perceived Pregnancy Risk
Contraception · Knowledge, Attitudes, Practice
Primary: Change in Contraceptive Knowledge Assessment (CKA) Score — 0.90; 1.6 scores on a scale — p=<0.0001
N/A N=4,488 National Prevalence and Impact of Noninvasive Prenatal Testing
Aneuploidy
Primary: Number of Patient Undergoing IDTFK Before (Control) and After (Test) NIPT Testing Came to Market — 1414; 3074 Participants
N/A N=360 Participate While Pregnant Survey
Pregnancy
Primary: Willingness to Participate in Research While Pregnant — 319; 39; 288; 70 Participants
Phase 4 N=711 RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC
Contraception
Primary: Percentage of Participants Reporting a Pregnancy — 0; 0.3 % of participants reporting pregnancy
Phase 2 N=80 Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
HIV Infections
Primary: Estimated Threshold of Maternal Steady-state Tenofovir Diphosphate (TFV-DP) Concentration Levels Corresponding to Optimal Adherence in the PK Component — 965; 1050…
N/A N=176 Technology-Based Intervention for Reducing Sexually Transmitted Infections and Substance Use During Pregnancy
Sexually Transmitted Infection · Alcohol Use Complicating the Puerperium · Alcohol Use Complicating Pregnancy, Unspecified Trimester
Primary: Unprotected Sexual Occasions (USOs) — 27.73; 41.50; 8.68; 14.70 USOs per participant — p=0.2964
Early Phase 1 N=14 Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor
HIV/AIDS · Adherence, Medication · Drug Use
Primary: Baseline TFV (Tenofovir) Levels in Plasma
Phase 4 N=37 Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir Alafenamide
Hiv
Primary: Percentage of Urine Samples Containing TFV in Concentrations Greater Than or Equal to 1000ng/mL From the 7-dose Cohort (1b). — 100; 80; 80; 80 percentage of urine samples
N/A N=23 Pilot Testing A Pregnancy Decision Making Tool for Women With Spinal Cord Injury (SCI)
Spinal Cord Injuries · Pregnancy Related
Primary: Final Decisional Conflict Scale Score - Values Clarity Sub-scale — 13.4 units on a scale
N/A N=185 Computerized Tool for Preventing Prenatal Drinking
Foetal Exposure During Pregnancy
Primary: Number of Participants Reporting Risky Alcohol Use — 99; 86; 60; 48 Participants
N/A N=960 PrEPARE: PrEP in Pregnancy, Accelerating Reach and Efficiency
Pre-Exposure Prophylaxis · HIV Infections · Pregnancy Related
Primary: PrEP Penetration — 30; 17; 46; 8 Participants
N/A N=13 Evaluation of Novel Point of Care Coagulation System in Pregnant Women
Hemorrhage · Coagulation Delay
Primary: Correlation of Fibrinogen in mg/dL Concentration With Clot Strength (CS hPa) and Fibrinogen Contribution to Clot (FCS hPa) of Point of the Care Quantra System. — 494…
N/A N=700 Ulipristal Emergency Contraception Used Before or After Ovulation
Contraception
Primary: Percentage of Pregnancies Prevented (PPP) — 77.5; 36.9 percentage of pregnancies prevented — p=<0.0001
Phase 3 N=255 Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
Persistent Pregnancy of Unknown Location · Ectopic Pregnancy
Primary: Number of Participants With Uneventful Clinical Resolution of a Pregnancy of Unknown Location Without Change From the Initial Management Strategy — 31; 42; 45 Participants
Phase 1 N=48 Computer-delivered Screening and Brief Intervention for Alcohol Use in Pregnancy
Alcohol Abuse
Primary: Alcohol Use — 18; 14 participants
Phase 3 N=3,597 A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
Pregnancy Prevention
Primary: All Users Pregnancy Rates Based on Pearl Index (PI) Analyses for 91-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight — 2.82; 2.46; 4.54…
N/A N=11 HSG and Tubal Patency Study
Tubal Patency
Primary: Number of Participants With Bilateral Tubal Patency as Assessed by HSG-follicular — 9; 1 Participants — p=0.4795